Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:20 PM
Ignite Modification Date:
2025-12-24 @ 11:20 PM
NCT ID:
NCT05584956
Eligibility Criteria:
Inclusion Criteria:
* Children with Beta thalassemia major who have increased TRJV more than 2.5m/s.
* Children age from 6-18 years
Exclusion Criteria:
* Others hemolytic anemia
* Young age before 6 years of age
* Allergy to Sildenafil or L-carnitine
* Patient with documented causes of pulmonary hypertension rather than caused by Beta thalassemia.
* Hepatic dysfunction: serum Alanine Aminotransferase (ALT) 3X.
* Renal dysfunction: Creatinine level greater than or equal to 1.2 mg/dl.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Years
Maximum Age:
18 Years
Study:
NCT05584956
Study Brief:
Protocol Section:
NCT05584956